Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
Author(s) | Date | Article Title |
Journal![]() |
---|---|---|---|
Lixia Wu, Lina Zhu, Kequn Xu, Siyuan Zhou, Yang Zhou, Tiening Zhang, Junjie Hang, Benny Chung-Ying Zee |
January 2021 | Clinical significance of site-specific metastases in pancreatic cancer: a study based on both clinical trial and real-world data | Journal of Cancer |
Jue Hou, Rachel Zhao, Tianrun Cai |
June 2022 | Temporal Trends in Clinical Evidence of 5-Year Survival Within Electronic Health Records Among Patients With Early-Stage Colon Cancer Managed With Laparoscopy-Assisted Colectomy vs Open Colectomy | JAMA Network Open |
Jean Coquet, PhD; Nicolas Bievre, MS; Vincent Billaut, MS; Martin Seneviratne, MD; Christopher J. Magnani, MPhil; Selen Bozkurt, PhD; James D. Brooks, MD; Tina Hernandez-Boussard, PhD |
February 2021 | Assessment of a Clinical Trial–Derived Survival Model in Patients With Metastatic Castration-Resistant Prostate Cancer | JAMA Network Open |
Sophia Z.Shalhout, PhD; Jong ChulPark, MD; Kevin S.Emerick,MD; Ryan J.Sullivan, MD; Howard L.Kaufman, MD; David M.MillerMD, PhD |
January 2021 | Real-world assessment of response to anti-PD-1 therapy in advanced cutaneous squamous cell carcinoma | Journal of the American Academy of Dermatology |
Shawn M. Sweeney, Hisham K. Hamadeh, Natalie Abrams, Stacey J. Adam, Sara Brenner, Dana E. Connors, Gerard J. Davis, Louis D. Fiore, Susan H. Gawel, Robert L. Grossman, Sean E. Hanlon, Karl Hsu, Gary J. Kelloff, Ilan R. Kirsch, Bill Louv, Deven McGraw, Frank Meng, Daniel Milgram, Robert S. Miller, Emily Morgan, Lata Mukundan, Thomas O'Brien, Paul Robbins, Eric H. Rubin, Wendy S. Rubinstein, Liz Salmi, Teilo H. Schaller, George Shi, Caroline C. Sigman, Sudhir Srivastava |
April 2023 | Case Studies for Overcoming Challenges in Using Big Data in Cancer | Cancer Research |
Shawn M. Sweeney, Hisham K. Hamadeh, Natalie Abrams, Stacey J. Adam, Sara Brenner, Dana E. Connors, Gerard J. Davis, Louis D. Fiore, Susan H. Gawel, Robert L. Grossman, Sean E. Hanlon, Karl Hsu, Gary J. Kelloff, Ilan R. Kirsch, Bill Louv, Deven McGraw, Frank Meng, Daniel Milgram, Robert S. Miller, Emily Morgan, Lata Mukundan, Thomas O'Brien, Paul Robbins, Eric H. Rubin, Wendy S. Rubinstein, Liz Salmi, Teilo H. Schaller, George Shi, Caroline C. Sigman, Sudhir Srivastava |
April 2023 | Challenges to Using Big Data in Cancer | Cancer Research |
Jiawei Zhou, Quefeng Li, Yanguang Cao |
February 2021 | Spatiotemporal Heterogeneity Across Metastases and Organ-Specific Response Informs Drug Efficacy and Patient Survival in Colorectal Cancer | Cancer Research |
L. Du, C. Yau, L. Brown-Swigart, R. Gould, G. Krings, G. L. Hirst, I. Bedrosian, R. M. Layman, J.M. Carter, M. Klein, S. Venters, S. Sonal, M. van der Noordaa, A. J. Chien, T. Haddad, C. Isaacs, L. Pusztai, K. Albain, R. Nanda, D. Tripathy, M.C. Liu, J. Boughey, R. Schwab, N. Hylton, A.DeMichele, J. Perlmutter, D. Yee, D. Berry, L. van’t Veer, V. Valero, L. Esserman, W. F.Symmans |
February 2021 | Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer prior to chemo-endocrine therapy | Annals of Oncology |
Kentaro Matsuura, Jun Tsuchida, Shuji Ando, Takashi Sozu |
March 2021 | Matrix decomposition in meta‐analysis for extraction of adverse event pattern and patient‐level safety profile | Pharmaceutical Statistics |
Wei-Xiang Qi, Yi Xiang, Shengguang Zhao & Jiayi Chen |
April 2021 | Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab | Cancer Immunology, Immunotherapy |
Zahra Azizi, Chaoyi Zheng, Lucy Mosquera, Louise Pilote, Khaled El Emam, GOING-FWD Collaborators Correspondence to Dr Khaled El Emam; kelemam@ehealthinformation.ca |
March 2021 | Can synthetic data be a proxy for real clinical trial data? A validation study | BMJ Open |
Kelsey H Natsuhara, Li Zhang, Christopher A Carlos, Hala T Borno |
April 2021 | Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study | Journal of Onco-Nephrology |
Felix D. Beacher, Lilianne R. Mujica-Parodi , Shreyash Gupta and Leonardo A. Ancora |
May 2021 | Machine Learning Predicts Outcomes of Phase III Clinical Trials for Prostate Cancer | Algorithms |
Geoffrey Fell, Robert A Redd, Alyssa M Vanderbeek, Rifaquat Rahman, Bill Louv, Jon McDunn, Andrea Arfè, Brian M Alexander, Steffen Ventz, Lorenzo Trippa |
June 2021 | KMDATA: a curated database of reconstructed individual patient-level data from 153 oncology clinical trials | Database |